|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.27 AUD | -1.72% |
|
+0.20% | -17.58% |
| 07-01 | Clinuvel Pharmaceuticals Extends CEO Philippe Wolgen's Term of Employment | MT |
| 06-15 | Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Bearish |
| Resistance | 10.6 | 10.6 | 11 |
| Spread/Res. | -3.11% | -3.11% | -6.64% |
| Spread/Supp. | +6.98% | +17.78% | +14.62% |
| Support | 9.6 | 8.72 | 8.96 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CUV Stock
- Charts Clinuvel Pharmaceuticals Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
